<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
BRTX
BioRestorative Therapies
$
()


  • BioRestorative's BRTX-100 trial to use sham injection control, says Roth MKM

    4/16/2024 - 11:31am
  • BioRestorative announces FDA clearance of Phase 2 BRTX-100 study protocol

    4/16/2024 - 07:50am
  • BioRestorative partners with Galen Patient Recruitment for BRTX-100 trial

    4/8/2024 - 07:47am
  • BioRestorative Therapies files registration statement of Form S-1

    4/3/2024 - 16:39pm
  • BioRestorative Therapies files to sell 2.51M shares of common stock for holders

    4/3/2024 - 16:20pm
  • BioRestorative announces exercise of warrants, issuance of new warrants

    2/6/2024 - 08:27am
  • BioRestorative presents preliminary data from Phase 2 study of BRTX-100

    2/5/2024 - 07:32am
  • BioRestorative Therapies to present preliminary BRTX-100 data at ORS meeting

    2/1/2024 - 07:32am
  • BioRestorative receive notice of allowance for patent app related to ThermoStem

    12/12/2023 - 09:19am
  • BioRestorative Therapies enters supply agreement with Evolutionary Biologics

    9/12/2023 - 09:03am
  • BioRestorative Therapies annnounces activation of Northwell Health in cLDD trial

    9/8/2023 - 08:35am
  • BioRestorative Therapies granted license to operate as tissue bank in NY

    7/21/2023 - 07:15am
  • BioRestorative to sell 685,033 shares at $3.03 in registered direct offering

    7/11/2023 - 08:40am
  • BioRestorative Therapies receives DSMB recommendation to continue Phase 2 trial

    7/7/2023 - 07:10am
  • BioRestorative Therapies receives DSMB recommendation to continue Phase 2 trial

    6/27/2023 - 07:03am
dynamic_feed Breaking News